Pilot study on sex hormone levels and fertility in women with malignant gliomas

Journal of Neuro-Oncology

Volumn 107, Issue 2, 2012, Pages 387-394

  Preusser, Matthias ^a   Seywald, Stefanie ^b   Elandt, Katarzyna ^a   Kurz, Christine ^c   Rottenfusser, Andrea ^a   Dieckmann, Karin ^a   Altorjai, Gabriele ^a   Zielinski, Christoph C ^a   Marosi, Christine ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Krankenhaus Rudolfstiftung   (Austria)

^c UNIV KLIN FÜR FRAUENHEILKUNDE   (Austria)

Author keywords

Anaplastic astrocytomas; Endocrine deficiency; Glioblastoma; Quality of life

Indexed keywords

DACARBAZINE; FOTEMUSTINE; HYPOPHYSIS HORMONE; IRINOTECAN; LIOTHYRONINE; LOMUSTINE; PROCARBAZINE; PROLACTIN; SEX HORMONE; TEMOZOLOMIDE; THYROTROPIN; THYROXINE; VINCRISTINE; ANTINEOPLASTIC AGENT;

ADULT; AMENORRHEA; ARTICLE; BRAIN RADIATION; CANCER GRADING; CLINICAL ARTICLE; CROSS-SECTIONAL STUDY; FATIGUE; FEMALE; FEMALE FERTILITY; FLUSHING; GLIOBLASTOMA; HORMONE BLOOD LEVEL; HORMONE DEFICIENCY; HUMAN; HYPOGONADISM; HYPOPHYSIS HORMONE BLOOD LEVEL; LIBIDO DISORDER; MENOPAUSAL SYNDROME; MENSTRUAL CYCLE; PHYSICAL ATTRACTIVENESS; PILOT STUDY; PREMENOPAUSE; PROLACTIN BLOOD LEVEL; QUALITY OF LIFE; SEX ROLE; THYROID HORMONE BLOOD LEVEL; TRANSVAGINAL ECHOGRAPHY; WEAKNESS; WEIGHT GAIN; BLOOD; BRAIN TUMOR; COMPUTER ASSISTED RADIOTHERAPY; DRUG EFFECT; FERTILITY; FOLLOW UP; GLIOMA; MENOPAUSE; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; TIME;

ADULT; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; FEMALE; FERTILITY; FOLLOW-UP STUDIES; GLIOMA; GONADAL STEROID HORMONES; HUMANS; MENOPAUSE; MIDDLE AGED; PILOT PROJECTS; QUALITY OF LIFE; RADIOTHERAPY, CONFORMAL; TIME FACTORS;

EID: 84863599116     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-011-0761-8     Document Type: Article

References (42)

1. Preusser M, de Ribaupierre S, Wohrer A, Erridge SC, Hegi M, Weller M, Stupp R (2011) Current concepts and management of glioblastoma. Ann Neurol 70:9-21
2. Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K, Hau P, Brandes AA, Gijtenbeek J, Marosi C, Vecht CJ, Mokhtari K, Wesseling P, Villa S, Eisenhauer E, Gorlia T, Weller M, Lacombe D, Cairncross JG, Mirimanoff RO (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10:459-466
3. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987-996
4. Taphoorn MJ, Sizoo EM, Bottomley A (2010) Review on quality of life issues in patients with primary brain tumors. Oncologist 15:618-626
5. Brandes AA, Pasetto LM, Lumachi F, Monfardini S (2000) Endocrine dysfunctions in patients treated for brain tumors: incidence and guidelines for management. J Neurooncol 47: 85-92
6. Constine LS, Woolf PD, Cann D, Mick G, McCormick K, Raubertas RF, Rubin P (1993) Hypothalamic-pituitary dysfunction after radiation for brain tumors. N Engl J Med 328:87-94
7. Darzy KH, Pezzoli SS, Thorner MO, Shalet SM (2007) Cranial irradiation and growth hormone neurosecretory dysfunction: a critical appraisal. J Clin Endocrinol Metab 92:1666-1672
8. Darzy KH (2009) Radiation-induced hypopituitarism after cancer therapy: who, how and when to test. Nat Clin Pract Endocrinol Metab 5:88-99
9. Oberfield SE, Nirenberg A, Allen JC, Cohen H, Donahue B, Prasad V, Schiff R, Pang S, Ghavimi F, David R, Chrousos G, Sklar C (1997) Hypothalamic- pituitary-adrenal function following cranial irradiation. Horm Res 47:9-16
10. Taphoorn MJ, Heimans JJ, van der Veen EA, Karim AB (1995) Endocrine functions in long-term survivors of low-grade supratentorial glioma treated with radiation therapy. J Neurooncol 25:97-102
11. Pai HH, Thornton A, Katznelson L, Finkelstein DM, Adams JA, Fullerton BC, Loeffler JS, Leibsch NJ, Klibanski A, Munzenrider JE (2001) Hypothalamic/pituitary function following high-dose conformal radiotherapy to the base of skull: demonstration of a dose-effect relationship using dose-volume histogram analysis. Int J Radiat Oncol Biol Phys 49:1079-1092
12. Littley MD, Shalet SM, Beardwell CG, Robinson EL, Sutton ML (1989) Radiation-induced hypopituitarism is dose-dependent. Clin Endocrinol (Oxf) 31:363-373
13. Duffner PK, Cohen ME, Voorhess ML, MacGillivray MH, Brecher ML, Panahon A, Gilani BB (1985) Long-term effects of cranial irradiation on endocrine function in children with brain tumors. A prospective study. Cancer 56:2189-2193
14. Duffner PK, Cohen ME, Anderson SW, Voorhess ML, MacGillivray MH, Panahon A, Brecher ML (1983) Long-term effects of treatment on endocrine function in children with brain tumors. Ann Neurol 14:528-532
15. Inoue T, Akahira J, Suzuki T, Darnel AD, Kaneko C, Takahashi K, Hatori M, Shirane R, Kumabe T, Kurokawa Y, Satomi S, Sasano H (2002) Progesterone production and actions in the human central nervous system and neurogenic tumors. J Clin Endocrinol Metab 87:5325-5331
16. Schneider HJ, Rovere S, Corneli G, Croce CG, Gasco V, Ruda R, Grottoli S, Stalla GK, Soffietti R, Ghigo E, Aimaretti G (2006) Endocrine dysfunction in patients operated on for non-pituitary intracranial tumors. Eur J Endocrinol 155:559-566
17. Rose SR, Danish RK, Kearney NS, Schreiber RE, Lustig RH, Burghen GA, Hudson MM (2005) ACTH deficiency in childhood cancer survivors. Pediatr Blood Cancer 45:808-813
18. Toogood AA, Ryder WD, Beardwell CG, Shalet SM (1995) The evolution of radiation-induced growth hormone deficiency in adults is determined by the baseline growth hormone status. Clin Endocrinol (Oxf) 43:97-103
19. Darzy KH, Shalet SM (2005) Hypopituitarism as a consequence of brain tumours and radiotherapy. Pituitary 8:203-211
20. Agha A, Sherlock M, Brennan S, O'Connor SA, O'Sullivan E, Rogers B, Faul C, Rawluk D, Tormey W, Thompson CJ (2005) Hypothalamic-pituitary dysfunction after irradiation of nonpituitary brain tumors in adults. J Clin Endocrinol Metab 90: 6355-6360
21. Fernandez A, Brada M, Zabuliene L, Karavitaki N, Wass JA (2009) Radiation-induced hypopituitarism. Endocr Relat Cancer 16:733-772
22. Emiliano AB, Fudge JL (2004) From galactorrhea to osteopenia: rethinking serotonin-prolactin interactions. Neuropsychopharmacology 29:833-846
23. Rosenbloom AL (2010) Hyperprolactinemia with antipsychotic drugs in children and adolescents. Int J Pediatr Endocrinol 2010
24. Wallace WH (2011) Oncofertility and preservation of reproductive capacity in children and young adults. Cancer 117: 2301-2310
25. Stahl PJ, Stember DS, Hsiao W, Schlegel PN (2010) Indications and strategies for fertility preservation in men. Clin Obstet Gynecol 53:815-827
26. Meirow D, Biederman H, Anderson RA, Wallace WH (2010) Toxicity of chemotherapy and radiation on female reproduction. Clin Obstet Gynecol 53:727-739
27. Su HI (2010) Measuring ovarian function in young cancer survivors. Minerva Endocrinol 35:259-270
28. Mah PM, Webster J (2002) Hyperprolactinemia: etiology, diagnosis, and management. Semin Reprod Med 20:365-374
29. Taphoorn MJ, Stupp R, Coens C, Osoba D, Kortmann R, van den Bent MJ, Mason W, Mirimanoff RO, Baumert BG, Eisenhauer E, Forsyth P, Bottomley A (2005) Health-related quality of life in patients with glioblastoma: a randomised controlled trial. Lancet Oncol 6:937-944
30. Taphoorn MJ, van den Bent MJ, Mauer ME, Coens C, Delattre JY, Brandes AA, Sillevis Smitt PA, Bernsen HJ, Frenay M, Tijssen CC, Lacombe D, Allgeier A, Bottomley A (2007) Healthrelated quality of life in patients treated for anaplastic oligodendroglioma with adjuvant chemotherapy: results of a European Organisation for Research and Treatment of Cancer randomized clinical trial. J Clin Oncol 25:5723-5730
31. Mauer M, Stupp R, Taphoorn MJ, Coens C, Osoba D, Marosi C, Wong R, de Witte O, Cairncross JG, Efficace F, Mirimanoff RO, Forsyth P, van den Bent MJ, Weller M, Bottomley A (2007) The prognostic value of health-related quality-of-life data in predicting survival in glioblastoma cancer patients: results from an international randomised phase III EORTC Brain Tumour and Radiation Oncology Groups, and NCIC Clinical Trials Group study. Br J Cancer 97:302-307
32. Mauer ME, Taphoorn MJ, Bottomley A, Coens C, Efficace F, Sanson M, Brandes AA, van der Rijt CC, Bernsen HJ, Frenay M, Tijssen CC, Lacombe D, van den Bent MJ (2007) Prognostic value of health-related quality-of-life data in predicting survival in patients with anaplastic oligodendrogliomas, from a phase III EORTC brain cancer group study. J Clin Oncol 25:5731-5737
33. Hottinger AF, Yoon H, DeAngelis LM, Abrey LE (2009) Neurological outcome of long-term glioblastoma survivors. J Neurooncol 95:301-305
34. Keir ST, Farland MM, Lipp ES, Friedman HS (2008) Distress persists in long-term brain tumor survivors with glioblastoma multiforme. J Cancer Surviv 2:269-274
35. Smith-Bindman R, Kerlikowske K, Feldstein VA, Subak L, Scheidler J, Segal M, Brand R, Grady D (1998) Endovaginal ultrasound to exclude endometrial cancer and other endometrial abnormalities. JAMA 280:1510-1517
36. Gupta JK, Chien PF, Voit D, Clark TJ, Khan KS (2002) Ultrasonographic endometrial thickness for diagnosing endometrial pathology in women with postmenopausal bleeding: a metaanalysis. Acta Obstet Gynecol Scand 81:799-816
37. Stranz G, Jakel F (1985) Psychological adjustment to breast amputation. Zentralbl Gynakol 107:1503-1509
38. Taphoorn MJ, Claassens L, Aaronson NK, Coens C, Mauer M, Osoba D, Stupp R, Mirimanoff RO, van den Bent MJ, Bottomley A (2010) An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients. Eur J Cancer 46:1033-1040
39. Schmiegelow M, Feldt-Rasmussen U, Rasmussen AK, Lange M, Poulsen HS, Muller J (2003) Assessment of the hypothalamopituitary-adrenal axis in patients treated with radiotherapy and chemotherapy for childhood brain tumor. J Clin Endocrinol Metab 88:3149-3154
40. van Santen HM, Vulsma T, Dijkgraaf MG, Blumer RM, Heinen R, Jaspers MW, Geenen MM, Offringa MO, de Vijlder JJ, van den Bos C (2003) No damaging effect of chemotherapy in addition to radiotherapy on the thyroid axis in young adult survivors of childhood cancer. J Clin Endocrinol Metab 88:3657-3663
41. Samaan NA, Schultz PN, Yang KP, Vassilopoulou-Sellin R, Maor MH, Cangir A, Goepfert H (1987) Endocrine complications after radiotherapy for tumors of the head and neck. J Lab Clin Med 109:364-372
42. Meacham LR, Mason PW, Sullivan KM (2004) Auxologic and biochemical characterization of the three phases of growth failure in pediatric patients with brain tumors. J Pediatr Endocrinol Metab 17:711-717